Asymptomatic Elevation of Amylase and Lipase After Olanzapine Treatment
| Authors | |
|---|---|
| Year of publication | 2016 |
| Type | Article in Periodical |
| Magazine / Source | JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY |
| MU Faculty or unit | |
| Citation | |
| Web | http://journals.lww.com/psychopharmacology/Citation/2016/04000/Asymptomatic_Elevation_of_Amylase_and_Lipase_After.18.aspx |
| Doi | http://dx.doi.org/10.1097/JCP.0000000000000460 |
| Field | Pharmacology and pharmaceutical chemistry |
| Keywords | ACUTE-PANCREATITIS |
| Description | Olanzapine, an atypical antipsychotic,has been considered one of the most efficient antipsychotic drugs, and it is the most frequently prescribed. It is categorized as a multiacting receptor targeted antipsychotic. The most significant adverse effects of olanzapine are metabolic: acute pancreatitis is one of the most serious adverse effects; fortunately, it does not occur very often. Koller et al1 found 51 cases,and at least 13 cases have been described more precisely. We present a case study of a young female patient with a very fast and high increase of amylase and lipase, who remained asymptomatic, immediately after olanzapine treatment. |
| Related projects: |